Maternal Hypertension Initiative

Hypertension is a common medical disorder in pregnancy in the United States. Preliminary data from PeriData.Net® show that in Wisconsin, hypertensive disorders affect approximately 22% of pregnancies. These disorders are also leading contributors to neonatal morbidity and mortality, with approximately 15-20% of NICU admissions being associated with maternal hypertension.

The aim of this initiative is to increase the number of providers (defined as hospitals or health systems) who use evidence-based protocols for screening and managing women with hypertension in the antepartum, intrapartum, and postpartum period. WisPQC accomplished this aim through the 2015 Regional Forum Series.

Cohort I (2016) focused on four quality measures:

  • Maternal length of stay
  • Provider education
  • Consumer education
  • NICU admission/transfer

Cohort II (2016) focused on seven quality measures:

  • Maternal length of stay
  • Consumer education
  • NICU admission/transfer
  • Low-dose aspirin with maternal risk factors
  • Appropriate medical management in less than 60 minutes
  • Debriefs for severe range hypertension
  • Severe maternal morbidity

View the quality measures, definitions, and data sources

Submit data or view the change package & data collection forms

Enroll in Hypertension Initiative

Data to InformTM–practice, policy, and research

Perinatal Hypertension-2016

Hypertensive disorders of pregnancy, including preeclampsia, complicate up to 10% of pregnancies worldwide, constituting one of the greatest causes of maternal and perinatal morbidity and mortality. In 2015, WisPQC introduced an initiative with the aim of educating providers about the practice changes recommended by the American College of Obstetricians and Gynecologists (ACOG) Task Force. This report summarizes the initiative.